Clinical Trial: Assessment of Circulating Leptin Levels in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07873749) titled 'Assessment of Circulating Leptin Levels in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease' on Oct. 08.

Brief Summary: This study aims to evaluate circulating leptin levels in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Leptin is an adipokine involved in metabolism and inflammation. The study will assess the association between serum leptin levels and the presence or severity of MASLD compared to controls.

Study Start Date: Oct. 15

Study Type: OBSERVATIONAL

Condition: Metabolic Dysfunction Associated Steatotic Liver Disease

Intervention: OTHER: Serum Leptin Measurement...